These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31480720)

  • 21. MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs.
    Pennati M; Folini M; Gandellini P; Zaffaroni N
    Curr Drug Targets; 2016; 17(3):257-65. PubMed ID: 25777275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
    Boeri M; Pastorino U; Sozzi G
    Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin and Lung Cancer: the Role of microRNAs.
    Lelli D; Pedone C; Majeed M; Sahebkar A
    Curr Pharm Des; 2017; 23(23):3440-3444. PubMed ID: 28067164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancer.
    Martinez-Perez C; Ward C; Cook G; Mullen P; McPhail D; Harrison DJ; Langdon SP
    Biochem Soc Trans; 2014 Aug; 42(4):1017-23. PubMed ID: 25109996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR‑144‑3p regulates the resistance of lung cancer to cisplatin by targeting Nrf2.
    Yin Y; Liu H; Xu J; Shi D; Zhai L; Liu B; Wang L; Liu G; Qin J
    Oncol Rep; 2018 Dec; 40(6):3479-3488. PubMed ID: 30542710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.
    Ortholan C; Puissegur MP; Ilie M; Barbry P; Mari B; Hofman P
    Curr Med Chem; 2009; 16(9):1047-61. PubMed ID: 19275611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel insights into the role of microRNA in lung cancer resistance to treatment and targeted therapy.
    Gong Z; Yang J; Li J; Yang L; Le Y; Wang S; Lin HK
    Curr Cancer Drug Targets; 2014; 14(3):241-58. PubMed ID: 24605945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer.
    Chen Y; Gao Y; Zhang K; Li C; Pan Y; Chen J; Wang R; Chen L
    Cell Physiol Biochem; 2015; 37(5):1869-80. PubMed ID: 26584286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs as therapeutic targets for lung cancer.
    Cho WC
    Expert Opin Ther Targets; 2010 Oct; 14(10):1005-8. PubMed ID: 20854177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
    Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
    Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs in human lung cancer.
    Kang SM; Lee HJ
    Exp Biol Med (Maywood); 2014 Nov; 239(11):1505-13. PubMed ID: 24872439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs and lung cancers: from pathogenesis to clinical implications.
    Qi J; Mu D
    Front Med; 2012 Jun; 6(2):134-55. PubMed ID: 22528868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer.
    Hasibuan PAZ; Simanjuntak Y; Hey-Hawkins E; Lubis MF; Rohani AS; Park MN; Kim B; Syahputra RA
    Biomed Pharmacother; 2024 Jul; 176():116827. PubMed ID: 38850646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.
    Borzi C; Calzolari L; Centonze G; Milione M; Sozzi G; Fortunato O
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results.
    Pasini A; Delmonte A; Tesei A; Calistri D; Giordano E
    Drugs; 2015 Oct; 75(15):1757-71. PubMed ID: 26347133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research Progress in Flavonoids as Potential Anticancer Drug Including Synergy with Other Approaches.
    Hussain Y; Luqman S; Meena A
    Curr Top Med Chem; 2020; 20(20):1791-1809. PubMed ID: 32357817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavonoids as anticancer agents: structure-activity relationship study.
    López-Lázaro M
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):691-714. PubMed ID: 12678721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research.
    Strissel PL; Strick R
    Leuk Res; 2005 Aug; 29(8):859-61. PubMed ID: 15967500
    [No Abstract]   [Full Text] [Related]  

  • 40. The Roles of MicroRNA in Lung Cancer.
    Wu KL; Tsai YM; Lien CT; Kuo PL; Hung AJ
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30935143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.